Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anticancer Research|July 7, 2021
Effects of Epstein-Barr Virus Infection on the Response of Human Breast Cancer Cells to NicotineLata Rajbongshi, Min Hye Noh, Yeong Seok Kim, et al.
Anticancer Research|March 27, 2024
Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal CarcinomaMin Hye Noh, Hye Young Kim, DO Hun Kim, et al.
Oncology Letters|October 5, 2020
Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicityJayoung Kim, Min Hye Noh, Dae Young Hur, et al.
Anticancer Research|December 31, 2021
Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer CellsSung Ho Moon, Nam-Sook Park, Min Hye Noh, et al.
Experimental and Therapeutic Medicine|April 24, 2023
APX‑115A, a pan‑NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ‑induced diabetic rat modelMin Hye Noh, Dong Kun Lee, Yeong Seok Kim, et al.
Current Eye Research|January 18, 2020
APX-115A, a pan-NADPH Oxidase Inhibitor, Induces Caspase-dependent Cell Death by Suppressing NOX4-ROS Signaling in EBV-infected Retinal Epithelial CellsSeung-Woo Hong, Min Hye Noh, Yeong Seok Kim, et al.
Anticancer Research|March 31, 2021
Erlotinib Activates Different Cell Death Pathways in EGFR-mutant Lung Cancer Cells Grown in 3D Versus 2D Culture SystemsHyun-Kyung Lee, Min Hye Noh, Seung-Woo Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathwaySeung-Woo Hong, Nam-Sook Park, Min Hye Noh, et al.
Neuro-Oncology|June 10, 2024
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Jin Muk Kang, Alexandra A Miller, et al.
Pageof 1